shot-button
Subscription Subscription
Home > Lifestyle News > Health And Fitness News > Article > Sale of anti diabetic medicines including insulin on the rise in India

Sale of anti-diabetic medicines, including insulin, on the rise in India

Updated on: 13 November,2017 07:56 PM IST  |  New Delhi
IANS |

Sales of anti-diabetic medicines, including insulin, has zoomed in India, along with the steadily increasing number of diabetics, says a study

Sale of anti-diabetic medicines, including insulin, on the rise in India

Sales of anti-diabetic medicines, including insulin, has zoomed in India, along with the steadily increasing number of diabetics, says a study. The findings led by Anoop Misra, Chairman at Fortis C-DOC Hospital, showed that from Rs 151.2 crore in 2008, the sale of insulin (especially newer insulin) rose to Rs 842 crore in 2016.


Sale of anti-diabetic medicines shoots up in India
The findings stated that the sale of insulin (especially newer insulin) rose to Rs 842 crore in 2016


Sales of oral drug (especially newer ones) also went up from Rs 278.5 crores in 2013 to Rs 700 crore in 2016. The spike could be attributed to the rising number of patients, increased availability and aggressive marketing by pharmaceutical companies. On the other hand, the affordability and accessibility of the anti-diabetic therapy to lower socio-economic strata remained inadequate, the study said.


"Increasing sales of high cost medications as shown by our data are particularly worrisome since most Indians pay out of their pocket and nearly seven per cent experience catastrophic expenditure for diabetes," Misra said. According to the World Health Organization (WHO), the number of adults suffering from diabetes has risen from 4.7 per cent of the global population in 1980 to 8.5 per cent in 2014.

Also read: Australian researchers develop diabetes drug to replace insulin injections

In 2015, the disease touted as lifestyle epidemic affected 415 million people worldwide while there were 69.1 million people with diabetes in India -- the second highest in the world after China, which had 109 million people, according to the report "Diabetes Atlas" released by the International Diabetes Federation (IDF).

"India has to take several stringent measures to ensure that there is a balancing mechanism in place, education of physicians, tighter regulations on price control and stricter norms for pharmaceutical companies around new drugs and marketing ethics," Misra added. The research was based on the data of sales trends from all top selling drugs (20 brands) for the past nine years (between December 2008 and December 2016), with emphasis on anti-diabetic drugs.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK